These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33711036)

  • 1. Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC.
    Loosen SH; Castoldi M; Jördens MS; Roy S; Vucur M; Kandler J; Hammerich L; Mohr R; Tacke F; Ulmer TF; Neumann UP; Luedde T; Roderburg C
    PLoS One; 2021; 16(3):e0247917. PubMed ID: 33711036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
    Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
    Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
    Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M
    Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma.
    Loosen SH; Wirtz TH; Roy S; Vucur M; Castoldi M; Schneider AT; Koppe C; Ulmer TF; Roeth AA; Bednarsch J; Alizai PH; Paffenholz P; Demir M; Trautwein C; Tacke F; Neumann UP; Roderburg C; Luedde T
    PLoS One; 2020; 15(9):e0239386. PubMed ID: 32960907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E
    Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F; Ying H; He B; Pan Y; Sun H; Wang S
    Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment.
    Cho HJ; Kim SS; Nam JS; Kim JK; Lee JH; Kim B; Wang HJ; Kim BW; Lee JD; Kang DY; Kim JH; Jae YM; Hwang JC; Shin SJ; Lee KM; Cho SW; Cheong JY
    Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):181-189. PubMed ID: 27839726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.
    Sun Q; Li J; Jin B; Wang T; Gu J
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):21-28. PubMed ID: 31053500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation.
    Sugimachi K; Matsumura T; Hirata H; Uchi R; Ueda M; Ueo H; Shinden Y; Iguchi T; Eguchi H; Shirabe K; Ochiya T; Maehara Y; Mimori K
    Br J Cancer; 2015 Feb; 112(3):532-8. PubMed ID: 25584485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
    Zhang C; Xia R; Zhang B; Wang H
    BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.
    Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S
    Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
    Jiang L; Li X; Cheng Q; Zhang BH
    Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serum microRNA-122 in hepatocellular carcinoma is dependent on coexisting clinical and laboratory factors.
    Franck M; Schütte K; Malfertheiner P; Link A
    World J Gastroenterol; 2020 Jan; 26(1):86-96. PubMed ID: 31933516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L; Lu B; Yu J; Liu W; Zhou A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.
    Köberle V; Kronenberger B; Pleli T; Trojan J; Imelmann E; Peveling-Oberhag J; Welker MW; Elhendawy M; Zeuzem S; Piiper A; Waidmann O
    Eur J Cancer; 2013 Nov; 49(16):3442-9. PubMed ID: 23810247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNAs in Hepatocellular Carcinoma: Potential Diagnostic and Prognostic Biomarkers.
    Mirzaei HR; Sahebkar A; Mohammadi M; Yari R; Salehi H; Jafari MH; Namdar A; Khabazian E; Jaafari MR; Mirzaei H
    Curr Pharm Des; 2016; 22(34):5257-5269. PubMed ID: 26935703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma.
    Cho HJ; Baek GO; Seo CW; Ahn HR; Sung S; Son JA; Kim SS; Cho SW; Jang JW; Nam SW; Cheong JY; Eun JW
    Cancer Med; 2020 Aug; 9(15):5459-5472. PubMed ID: 32537885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.